Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Trends in Molecular Medicine|March 14, 2017
A Brighter Side to Thalidomide: Its Potential Use in Immunological DisordersDavid Millrine, Tadamitsu KishimotoThe FEBS Journal|January 21, 2023
A guide to UFMylation, an emerging posttranslational modificationDavid Millrine, Joshua J Peter, Yogesh KulathuProceedings of the National Academy of Sciences of the United States of America|September 8, 2016
Rabex-5 is a lenalidomide target molecule that negatively regulates TLR-induced type 1 IFN productionDavid Millrine, Mami Tei, Yohannes Gemechu, et al.Methods in Molecular Biology (Clifton, N.J.)|January 12, 2018
Tracking Competent Host Defence to Chronic Inflammation: An In Vivo Model of PeritonitisJavier Uceda Fernandez, David Millrine, Simon A JonesTrends in Cancer|December 9, 2025
Small-cell lung cancer: anatomy of an immune-cold tumorDavid Millrine, Kathryn L Simpson, Fiona Blackhall, et al.FEBS Letters|October 7, 2021
Making sense of IL-6 signalling cues in pathophysiologyDavid Millrine, Robert H Jenkins, Stuart T O Hughes, et al.Methods in Molecular Biology (Clifton, N.J.)|June 24, 2023
Tracking the Host Response to Infection in Peritoneal Models of Acute Resolving InflammationDavid Millrine, Christopher M Rice, Javier U Fernandez, et al.Biochemical and Biophysical Research Communications|December 10, 2014
A panel of recombinant monoclonal antibodies against zebrafish neural receptors and secreted proteins suitable for wholemount immunostainingNicole Staudt, Nicole Müller-Sienerth, Alla Fane-Dremucheva, et al.Proceedings of the National Academy of Sciences of the United States of America|October 31, 2018
Humanized cereblon mice revealed two distinct therapeutic pathways of immunomodulatory drugsYohannes Gemechu, David Millrine, Shigeru Hashimoto, et al.International Immunology|February 12, 2016
Immunomodulatory drugs inhibit TLR4-induced type-1 interferon production independently of Cereblon via suppression of the TRIF/IRF3 pathwayDavid Millrine, Haruhiko Miyata, Mami Tei, et al.Pageof 2